What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
His primary areas of study are Internal medicine, Pharmacology, Randomized controlled trial, Curcumin and Endocrinology.
His Internal medicine study combines topics in areas such as Gastroenterology and Placebo.
He has researched Pharmacology in several fields, including Statin, Nutraceutical, Web of science and Chemotherapy.
Amirhossein Sahebkar usually deals with Randomized controlled trial and limits it to topics linked to Meta-analysis and Confidence interval and Clinical trial.
His Curcumin research incorporates themes from Tumor necrosis factor alpha, Cancer research, Inflammation, Adverse effect and Curcuma.
His study in Endocrinology is interdisciplinary in nature, drawing from both Peroxisome proliferator-activated receptor and Fatty liver.
His most cited work include:
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 (2508 citations)
- Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017 (1735 citations)
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017 : a systematic analysis for the Global Burden of Disease Study 2017 (1257 citations)
What are the main themes of his work throughout his whole career to date?
Amirhossein Sahebkar spends much of his time researching Internal medicine, Pharmacology, Meta-analysis, Randomized controlled trial and Endocrinology.
His Internal medicine research includes themes of Gastroenterology and Placebo.
His biological study spans a wide range of topics, including Statin, Oxidative stress, Dyslipidemia and Inflammation.
His Meta-analysis research integrates issues from Oncology and Confidence interval.
His Endocrinology study is mostly concerned with Lipoprotein and Diabetes mellitus.
His Curcumin research is multidisciplinary, relying on both Cancer and Cancer research.
He most often published in these fields:
- Internal medicine (45.35%)
- Pharmacology (23.06%)
- Meta-analysis (21.06%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (45.35%)
- Pharmacology (23.06%)
- Disease (8.53%)
In recent papers he was focusing on the following fields of study:
Amirhossein Sahebkar mainly focuses on Internal medicine, Pharmacology, Disease, Cancer research and Inflammation.
His research integrates issues of Gastroenterology, Endocrinology and Oncology in his study of Internal medicine.
His Pharmacology study incorporates themes from Diabetes mellitus and Drug delivery.
His studies deal with areas such as Cancer, Metastasis, Apoptosis, Signal transduction and Curcumin as well as Cancer research.
His work carried out in the field of Inflammation brings together such families of science as Receptor and Pathogenesis.
His Clinical trial study combines topics from a wide range of disciplines, such as Placebo and Randomized controlled trial.
Between 2019 and 2021, his most popular works were:
- Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (224 citations)
- Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (163 citations)
- Statins and the Covid-19 main protease: In silico evidence on direct interaction (91 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
His scientific interests lie mostly in Disease, Pharmacology, Internal medicine, Inflammation and Cancer research.
The Disease study combines topics in areas such as Bioinformatics, Central nervous system, microRNA, Global health and Multiple sclerosis.
The concepts of his Pharmacology study are interwoven with issues in Statin and Antimicrobial.
Amirhossein Sahebkar combines subjects such as Gastroenterology, Endocrinology and Oncology with his study of Internal medicine.
Amirhossein Sahebkar has included themes like Receptor, Immune system and Scavenger receptor in his Inflammation study.
The various areas that he examines in his Randomized controlled trial study include Placebo and Clinical trial.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
